TY - JOUR
T1 - Radiation therapy associated invasive bladder tumors
AU - Sella, Avishay
AU - Dexeus, Francisco H.
AU - Chong, Clayton
AU - Ro, Jae Y.
AU - Logothetis, Christopher J.
PY - 1989/3
Y1 - 1989/3
N2 - Radiotherapy-associated bladder carcinoma was found in 3. 7 percent of 244 cases of advanced urothelial carcinoma. Average age at diagnosis of the bladder tumor was 63.1 years, with a mean of 20.5 years between radiation treatment and diagnosis. All 9 patients presented with gross hematuria. Eight patients had transitional cell carcinoma, 7/8 (87.5%) also had vascular or lymphatic invasion, and 1 was adenocarcinoma. Mean survival was 15.4 months (range 1-40 mos.), with a 55.5 percent one-year disease free survival after diagnosis. Four patients died of bladder tumor, 4 were alive with no evidence of disease, and 1 was alive with metastasis.
AB - Radiotherapy-associated bladder carcinoma was found in 3. 7 percent of 244 cases of advanced urothelial carcinoma. Average age at diagnosis of the bladder tumor was 63.1 years, with a mean of 20.5 years between radiation treatment and diagnosis. All 9 patients presented with gross hematuria. Eight patients had transitional cell carcinoma, 7/8 (87.5%) also had vascular or lymphatic invasion, and 1 was adenocarcinoma. Mean survival was 15.4 months (range 1-40 mos.), with a 55.5 percent one-year disease free survival after diagnosis. Four patients died of bladder tumor, 4 were alive with no evidence of disease, and 1 was alive with metastasis.
UR - http://www.scopus.com/inward/record.url?scp=0024597730&partnerID=8YFLogxK
U2 - 10.1016/0090-4295(89)90387-7
DO - 10.1016/0090-4295(89)90387-7
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 2919477
AN - SCOPUS:0024597730
SN - 0090-4295
VL - 33
SP - 185
EP - 188
JO - Urology
JF - Urology
IS - 3
ER -